> top > docs > PMC:7264098 > spans > 18901-20310 > annotations

PMC:7264098 / 18901-20310 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PMC-OGER-BB

Id Subject Object Predicate Lexical cue
T292 78-89 UBERON:0001004 denotes respiratory
T293 107-115 SP_7 denotes COVID-19
T294 231-239 SP_7 denotes COVID-19
T295 316-324 SP_7 denotes COVID-19
T296 364-368 DG_47 denotes MSCs
T297 496-502 NCBITaxon:9606 denotes humans
T298 543-552 CL:0000034 denotes stem cell
T299 861-871 CL:0000034 denotes stem cells
T300 881-889 SP_7 denotes COVID-19
T301 1029-1038 CL:0000034 denotes stem cell
T302 1204-1214 CL:0000034 denotes stem cells
T303 1253-1258 SP_6;NCBITaxon:9606 denotes human
T304 1307-1312 UBERON:0000062 denotes organ
T305 1378-1388 CL:0000034 denotes stem cells
T82510 78-89 UBERON:0001004 denotes respiratory
T6643 107-115 SP_7 denotes COVID-19
T21007 231-239 SP_7 denotes COVID-19
T21172 316-324 SP_7 denotes COVID-19
T22857 364-368 DG_47 denotes MSCs
T94386 496-502 NCBITaxon:9606 denotes humans
T33075 543-552 CL:0000034 denotes stem cell
T82991 861-871 CL:0000034 denotes stem cells
T90311 881-889 SP_7 denotes COVID-19
T26981 1029-1038 CL:0000034 denotes stem cell
T90467 1204-1214 CL:0000034 denotes stem cells
T54766 1253-1258 SP_6;NCBITaxon:9606 denotes human
T48295 1307-1312 UBERON:0000062 denotes organ
T65823 1378-1388 CL:0000034 denotes stem cells

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
421 240-248 Species denotes patients Tax:9606
422 496-502 Species denotes humans Tax:9606
423 1253-1258 Species denotes human Tax:9606
424 1161-1164 Chemical denotes GMP
425 78-103 Disease denotes respiratory complications MESH:D012131
426 107-115 Disease denotes COVID-19 MESH:C000657245
427 231-239 Disease denotes COVID-19 MESH:C000657245
428 316-324 Disease denotes COVID-19 MESH:C000657245
429 881-889 Disease denotes COVID-19 MESH:C000657245

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T138 543-552 Body_part denotes stem cell http://purl.org/sig/ont/fma/fma63368
T139 548-552 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T140 861-871 Body_part denotes stem cells http://purl.org/sig/ont/fma/fma63368
T141 866-871 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T142 1029-1038 Body_part denotes stem cell http://purl.org/sig/ont/fma/fma63368
T143 1034-1038 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T144 1204-1214 Body_part denotes stem cells http://purl.org/sig/ont/fma/fma63368
T145 1209-1214 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T146 1307-1312 Body_part denotes organ http://purl.org/sig/ont/fma/fma67498
T147 1378-1388 Body_part denotes stem cells http://purl.org/sig/ont/fma/fma63368
T148 1383-1388 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646

LitCovid-PD-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T37 1307-1312 Body_part denotes organ http://purl.obolibrary.org/obo/UBERON_0000062

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T134 107-115 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T135 231-239 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T136 316-324 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T137 881-889 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T201 117-118 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T202 496-502 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes humans
T203 543-552 http://purl.obolibrary.org/obo/CL_0000034 denotes stem cell
T204 709-710 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T205 861-871 http://purl.obolibrary.org/obo/CL_0000034 denotes stem cells
T206 951-952 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T207 1029-1038 http://purl.obolibrary.org/obo/CL_0000034 denotes stem cell
T208 1158-1159 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T209 1204-1214 http://purl.obolibrary.org/obo/CL_0000034 denotes stem cells
T210 1221-1222 http://purl.obolibrary.org/obo/CLO_0001021 denotes b
T211 1224-1231 http://purl.obolibrary.org/obo/UBERON_0000473 denotes testing
T212 1253-1258 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes human
T213 1307-1312 http://purl.obolibrary.org/obo/UBERON_0003103 denotes organ
T214 1367-1374 http://purl.obolibrary.org/obo/UBERON_0000473 denotes testing
T215 1378-1388 http://purl.obolibrary.org/obo/CL_0000034 denotes stem cells

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T60 421-424 Chemical denotes GMP http://purl.obolibrary.org/obo/CHEBI_17345|http://purl.obolibrary.org/obo/CHEBI_58115
T62 1161-1164 Chemical denotes GMP http://purl.obolibrary.org/obo/CHEBI_17345|http://purl.obolibrary.org/obo/CHEBI_58115

LitCovid-PD-GO-BP

Id Subject Object Predicate Lexical cue
T24 445-456 http://purl.obolibrary.org/obo/GO_0065007 denotes regulations

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T114 0-249 Sentence denotes Despite the lack of convincing evidence in support of MSC-based therapies for respiratory complications of COVID-19, a number of promising trials are currently underway, which could revolutionize the treatment prospects for severe COVID-19 patients.
T115 250-503 Sentence denotes Regardless of the urgency of the need for MSC-based therapies for COVID-19, it is critical that the production of MSCs is in compliance with good manufacturing practices (GMP) and follows strict regulations prior to being approved for the use in humans.
T116 504-654 Sentence denotes The use of unauthorized and unapproved stem cell therapies not validated through stringent multicenter clinical trials should be strongly discouraged.
T117 655-919 Sentence denotes At the same time current findings imply that there is a need for globally coordinated approach and support to conduct multicenter clinical trials to demonstrate safety and effectiveness of various types of stem cells to treat COVID-19-induced health complications.
T118 920-1119 Sentence denotes It also suggests that there is a need in biomedical research and development to establish the most effective stem cell types that are ideally suited for the treatment of aforementioned complications.
T119 1120-1409 Sentence denotes These developments will also require (a) GMP compliant technologies to mass produce stem cells, and (b) testing platforms that mimic human pathophysiology (e.g., 3D bioprinted organoids, organ-on-chip) to allow high-throughput screening and rapid testing of stem cells safety and efficacy.